Trade NORD stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Nordicus Partners Corporation (NORD) is trading at US$2.99, up 1.39% today as of Nov 11, 16:00 EST. The company has a market capitalisation of US$82.47M. Over the past 52 weeks, NORD has traded between US$2.87 and US$5.15. On Syfe you can trade NORD with $0 commission and add it to your watchlist.
| Previous close | US$2.95 |
|---|---|
| Market cap | US$82.47M |
| 52-week range | US$2.87 – US$5.15 |
| Volume | 3.03K |
| Exchange | US |
Nordicus Partners Corporation
Nordicus Partners Corp. is a biotech company, which specializes in developing breakthrough therapeutics in diseases with unmet medical needs. It focuses on acquisition and development of drugs from innovative biotech companies in the Nordics. The company was founded on April 7, 1993 and is headquartered in Beverly Hills, CA.
Nordicus Partners Corporation (NORD) stock is trading at US$2.99, +1.39% from the previous close of US$2.95.
The market cap for Nordicus Partners Corporation (NORD) stock is approximately US$82.47M.
The 52-week high for Nordicus Partners Corporation (NORD) stock is US$5.15.
The 52-week low for Nordicus Partners Corporation (NORD) stock is US$2.87.
Nordicus Partners Corporation (NORD) does not currently pay a dividend.
Stay on top of NORD
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
